{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":1,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"d3ac228749f7","filters":{"venue":"Asia Pacific Clinical and Translational Nervous System Diseases"}},"results":[{"id":"W2501244108","doi":"10.4103/2468-5577.187082","title":"Seven alternative opportunities to overcome the \"Valley of Death\" for CNS drug candidates developed by academic researchers","year":2016,"lang":"en","type":"article","venue":"Asia Pacific Clinical and Translational Nervous System Diseases","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Drug; Medicine; Intensive care medicine; Pharmacology","authors":[{"name":"Pierre A. Guertin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2441513627045625,"gpt":0.3825053458334726,"spread":0.1383539831289101,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007697289,0.0008456737,0.0008877385,0.002313178,0.002064663,0.005981809,0.001330606,0.004983678,0.02535213],"category_scores_gemma":[0.01061282,0.000419118,0.001481858,0.001308782,0.002955308,0.007314904,0.005202854,0.004432822,0.001702188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001876341,"about_ca_system_score_gemma":0.00358206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006250365,"about_ca_topic_score_gemma":0.001516248,"domain_scores_codex":[0.9953852,0.002726596,0.0002033011,0.0002542236,0.0007874726,0.0006432996],"domain_scores_gemma":[0.9910361,0.005758246,0.001035431,0.0003645464,0.0007223649,0.001083421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003160532,0.000207534,0.002227684,0.0006671057,0.00005403976,0.0004238164,0.0002466051,0.002954765,0.0004667904,0.8573069,0.02579661,0.1093321],"study_design_scores_gemma":[0.0005073538,0.0005486237,0.003872516,0.001301356,0.00006001896,0.0006218019,0.001107416,0.01044426,0.0008436674,0.8217182,0.158815,0.0001596836],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"commentary","genre_scores_codex":[0.1099608,0.0855761,0.1832332,0.2764654,0.002980008,0.0008599123,0.001158549,0.0007934824,0.3389725],"genre_scores_gemma":[0.761695,0.04594627,0.1253373,0.01615927,0.002719242,0.001481594,0.0006706659,0.0001322403,0.04585843],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.02535213,"threshold_uncertainty_score":0.08481127,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}